Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis

Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis

Abstract Serum neurofilament light chain (NfL) is emerging as an important biomarker in multiple sclerosis (MS). Our objective was to evaluate the prognostic value of serum NfL levels obtained close to the time of MS onset with long-term clinical outcomes. In this prospective cohort study, we identi...

Full description

Bibliographic Details
Main Authors: Simon Thebault, Mohammad Abdoli, Seyed-Mohammad Fereshtehnejad, Daniel Tessier, Vincent Tabard-Cossa, Mark S. Freedman
Format: Article
Language:English
Published: Nature Publishing Group 2020-06-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-020-67504-6

Internet

https://doi.org/10.1038/s41598-020-67504-6

Similar Items